Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | SETDB1 | Q15047 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17952599 | 0.91 | CASP3 (0.36) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952312 | 0.89 | CASP3 (0.35) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952314 | 0.87 | CASP3 (0.35) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952597 | 0.85 | CASP3 (0.36) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952369 | 0.85 | CASP3 (0.36) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952488 | 0.85 | CASP3 (0.36) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952629 | 0.82 | CASP3 (0.36) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL21688806 | 0.82 | CASP3 (0.45) | CASP3HTR2AHTR2CHTR2BHTR7 | |
| SCHEMBL17952192 | 0.81 | MEN1 (0.33) | MAOB | |
| SCHEMBL17952376 | 0.81 | CASP3 (0.35) | CASP3HTR2AHTR2CHTR2BHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | CASP3 1740/4885HTR2A 2464/4885HTR2C 2735/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | CASP3 1740/4885HTR2A 2464/4885HTR2C 2735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.